Hydroxcel_500_Hydroxyurea

Hydroxcel 500 – Hydroxyurea

Hydroxyurea

Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia

Hydroxcel 500 contains Hydroxyurea 500 mg, an antineoplastic medication used in the treatment of certain cancers and hematological disorders. It works by inhibiting DNA synthesis in rapidly dividing cells, helping to control disease progression and support established treatment protocols in oncology and hematology.

Contain

Hydroxyurea

Strength

500 mg

Packaging

10X10CAP

Category

Categories:

Manufacturer

Baker & Davis Private Limited

Brand

Hydroxcel

SEND US A MESSAGE

    CONTACT INFORMATION

    501, EAST BAY, BAYVUE, DR M B VELKAR MARG,
    KALBADEVI, MUMBAI-400002.

    +91 96531 13180

    sales@vinixbiopharma.com

    Do you have questions about how we can help your company? Send us an email and we’ll get in touch shortly.

    Product Overview

    Hydroxcel 500 contains Hydroxyurea, a well-established antineoplastic and cytoreductive agent widely used in the management of various hematological disorders and certain malignancies. Hydroxyurea has been extensively utilized in clinical practice for its ability to reduce abnormal cell proliferation and support effective disease management. Its proven therapeutic profile has made it an important treatment option in both oncology and hematology.

    The medicine is commonly prescribed under the supervision of qualified healthcare professionals and is used in hospitals, specialty clinics, and healthcare institutions worldwide. Hydroxyurea plays a significant role in helping physicians manage conditions associated with excessive cell production while supporting long-term treatment strategies.


    How It Works

    Hydroxyurea works by inhibiting DNA synthesis within rapidly dividing cells. By interfering with cellular replication processes, it helps slow the growth and multiplication of abnormal cells. This mechanism contributes to disease control and supports effective management of various hematological and oncological conditions.


    Therapeutic Applications

    Hydroxcel 500 may be prescribed as part of treatment protocols for:

    • Chronic Myeloid Leukemia (CML)
    • Head and Neck Cancers
    • Polycythemia Vera
    • Essential Thrombocythemia
    • Sickle Cell Disease
    • Other hematological and oncological conditions as determined by the treating physician

    The medicine may be used as part of comprehensive treatment plans depending on individual patient requirements.


    Key Benefits

    • Established antineoplastic and cytoreductive therapy.
    • Supports the management of hematological disorders.
    • Helps control abnormal cell proliferation.
    • Widely used in oncology and hematology treatment protocols.
    • Suitable for long-term disease management under medical supervision.
    • Manufactured under stringent pharmaceutical quality standards.

    Quality Commitment

    Vinix Biopharma is committed to delivering high-quality pharmaceutical products that meet rigorous industry standards. Hydroxcel 500 is manufactured under controlled production environments and undergoes comprehensive quality assurance procedures to ensure consistency, safety, and reliability. Every batch is carefully evaluated to maintain product integrity and support effective patient care.


    Storage Information

    Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.


    Disclaimer

    Hydroxcel 500 should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be determined by the treating physician based on the patient’s medical condition, clinical assessment, and therapeutic requirements.